Copyright Reports & Markets. All rights reserved.

Global Molecular Diagnostics Cancer Market Status and Forecast 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Molecular Diagnostics Cancer Market Status and Forecast (2016-2027)
      • 1.3.2 Global Molecular Diagnostics Cancer Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Molecular Diagnostics Cancer Supply by Company

    • 2.1 Global Molecular Diagnostics Cancer Sales Value by Company
    • 2.2 Molecular Diagnostics Cancer Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Molecular Diagnostics Cancer Market Status by Type

    • 3.1 Molecular Diagnostics Cancer Type Introduction
      • 3.1.1 Pharmacogenomic Diagnosis
      • 3.1.2 Liquid Biopsy
      • 3.1.3 Other
    • 3.2 Global Molecular Diagnostics Cancer Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Molecular Diagnostics Cancer Market Status by Application

    • 4.1 Molecular Diagnostics Cancer Segment by Application
      • 4.1.1 Respiratory Cancer
      • 4.1.2 Cancer of Digestive System
      • 4.1.3 Cancer of Urinary System
      • 4.1.4 Cancer of Circulatory System
      • 4.1.5 Motor System Cancer
      • 4.1.6 Reproductive System Cancer
      • 4.1.7 Other
    • 4.2 Global Molecular Diagnostics Cancer Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Molecular Diagnostics Cancer Market Status by Region

    • 5.1 Global Molecular Diagnostics Cancer Market by Region
    • 5.2 North America Molecular Diagnostics Cancer Market Status
    • 5.3 Europe Molecular Diagnostics Cancer Market Status
    • 5.4 Asia Pacific Molecular Diagnostics Cancer Market Status
    • 5.5 Central & South America Molecular Diagnostics Cancer Market Status
    • 5.6 Middle East & Africa Molecular Diagnostics Cancer Market Status

    6 North America Molecular Diagnostics Cancer Market Status

    • 6.1 North America Molecular Diagnostics Cancer Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Molecular Diagnostics Cancer Market Status

    • 7.1 Europe Molecular Diagnostics Cancer Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Molecular Diagnostics Cancer Market Status

    • 8.1 Asia Pacific Molecular Diagnostics Cancer Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Molecular Diagnostics Cancer Market Status

    • 9.1 Central & South America Molecular Diagnostics Cancer Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Molecular Diagnostics Cancer Market Status

    • 10.1 Middle East & Africa Molecular Diagnostics Cancer Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Molecular Diagnostics Cancer Market Forecast by Type and by Application

    • 12.1 Global Molecular Diagnostics Cancer Sales Value Forecast (2022-2027)
    • 12.2 Global Molecular Diagnostics Cancer Forecast by Type
    • 12.3 Global Molecular Diagnostics Cancer Forecast by Application

    13 Global Molecular Diagnostics Cancer Market Forecast by Region/Country

    • 13.1 Global Molecular Diagnostics Cancer Market Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Thermo Fisher Scientific
      • 14.1.1 Company Information
      • 14.1.2 Molecular Diagnostics Cancer Product Introduction
      • 14.1.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Siemens
      • 14.2.1 Company Information
      • 14.2.2 Molecular Diagnostics Cancer Product Introduction
      • 14.2.3 Siemens Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Roche
      • 14.3.1 Company Information
      • 14.3.2 Molecular Diagnostics Cancer Product Introduction
      • 14.3.3 Roche Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 PlexBio
      • 14.4.1 Company Information
      • 14.4.2 Molecular Diagnostics Cancer Product Introduction
      • 14.4.3 PlexBio Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Merck
      • 14.5.1 Company Information
      • 14.5.2 Molecular Diagnostics Cancer Product Introduction
      • 14.5.3 Merck Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 MDxHealth
      • 14.6.1 Company Information
      • 14.6.2 Molecular Diagnostics Cancer Product Introduction
      • 14.6.3 MDxHealth Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Luminex
      • 14.7.1 Company Information
      • 14.7.2 Molecular Diagnostics Cancer Product Introduction
      • 14.7.3 Luminex Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Invitae
      • 14.8.1 Company Information
      • 14.8.2 Molecular Diagnostics Cancer Product Introduction
      • 14.8.3 Invitae Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 ICON Plc
      • 14.9.1 Company Information
      • 14.9.2 Molecular Diagnostics Cancer Product Introduction
      • 14.9.3 ICON Plc Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Guardant Health
      • 14.10.1 Company Information
      • 14.10.2 Molecular Diagnostics Cancer Product Introduction
      • 14.10.3 Guardant Health Molecular Diagnostics Cancer Sales Value, Gross Margin and Global Share (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 GenomOncology
    • 14.12 Foundation Medicine
    • 14.13 Danaher
    • 14.14 CytoTrack
    • 14.15 Bio-Techne
    • 14.16 Biodesix
    • 14.17 Biocartis
    • 14.18 AstraZeneca
    • 14.19 Abbott Laboratories
    • 14.20 10X Genomics

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Molecular Diagnostics Cancer market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Molecular Diagnostics Cancer industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Molecular Diagnostics Cancer market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Molecular Diagnostics Cancer Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics Cancer market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Molecular Diagnostics Cancer Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Molecular Diagnostics Cancer industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Pharmacogenomic Diagnosis
      Liquid Biopsy
      Other

      Segmented by Application
      Respiratory Cancer
      Cancer of Digestive System
      Cancer of Urinary System
      Cancer of Circulatory System
      Motor System Cancer
      Reproductive System Cancer
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Thermo Fisher Scientific
      Siemens
      Roche
      PlexBio
      Merck
      MDxHealth
      Luminex
      Invitae
      ICON Plc
      Guardant Health
      GenomOncology
      Foundation Medicine
      Danaher
      CytoTrack
      Bio-Techne
      Biodesix
      Biocartis
      AstraZeneca
      Abbott Laboratories
      10X Genomics
      Buy now